Anthracyclines for gestational breast cancer: course and outcome of pregnancy

Ann Oncol. 2008 Aug;19(8):1511-1512. doi: 10.1093/annonc/mdn396. Epub 2008 Jun 18.

Authors

H A Azim Jr¹, F A Peccatori², G Scarfone³, B Acaia³, P Rossi³, R Cascio¹, A Goldhirsch¹

Affiliations

¹ Department of Medicine, European Institute of Oncology.
² Department of Medicine, European Institute of Oncology. Electronic address: fedro.peccatori@ieo.it.
³ Division of Obstetrics and Gynaecology, IRCCS Policlinico, Mangiagalli and Regina Elena, University of Milan, Milan, Italy.

PMID: 18562327
DOI: 10.1093/annonc/mdn396

No abstract available

Publication types

Letter

MeSH terms

Adult
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Breast Neoplasms / drug therapy*
Doxorubicin / administration & dosage
Doxorubicin / adverse effects
Epirubicin / administration & dosage
Epirubicin / adverse effects
Female
Humans
Pregnancy
Pregnancy Complications, Neoplastic / drug therapy*
Pregnancy Outcome

Substances

Epirubicin
Doxorubicin